~~<i id='19D5D6420E'><strike id='19D5D6420E'><tt id='19D5D6420E'><pre id='19D5D6420E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：knowledge 2025-09-30 21:27:12 - browse：729

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout Newsletter: Illumina, CRISPR, Regeneron

hotspot

focus

knowledge

focus

leisure time

hotspot

Fromlefttoright,STAT'sDamianGarde;MikaelDolsten,chiefscientificofficerofPfizerresearchanddevelopment

WSS

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Europe sees delivery challenges ahead on Alzheimer's therapies

Woman gored by Bison at Yellowstone

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Pregnancy ages women, but effects reverse after delivery

knowledge

explore

hotspot

Activists slam private health insurers over coverage restrictions

Blood tests recalled over risk of missed heart attack diagnosis

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Walensky prepares to leave CDC — and Congress — behind

Blood tests recalled over risk of missed heart attack diagnosis

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Eli Lilly to acquire Versanis in heated race for weight loss drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Diabetes management: Digital health tools fall short, study says

focus

Yancopoulos of Regeneron works to expand Dupixent success

Biotech investment managers search for lucrative opportunities

Can CDC director Mandy Cohen drive consensus in Washington?

Who gets to use the title 'doctor'?

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

knowledge

focus

leisure time

hotspot